This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cfs [06.12.2019] – [Recent research] sallieq | home:diseases:cfs [07.06.2019] – [Research] sallieq | ||
---|---|---|---|
Line 63: | Line 63: | ||
The absence of clear laboratory markers affects not only how CFS is diagnosed, but whether or not it is viewed as fundamentally psychological illness, and how it is treated. | The absence of clear laboratory markers affects not only how CFS is diagnosed, but whether or not it is viewed as fundamentally psychological illness, and how it is treated. | ||
- | ==== Recent research | + | ==== Research |
+ | |||
+ | There is considerable evidence that mitochondrial dysfunction is present in some CFS patients. (({{pubmed> | ||
This work contributes key elements to the development of ME/CFS diagnostics, | This work contributes key elements to the development of ME/CFS diagnostics, | ||
Line 71: | Line 73: | ||
Altered composition of the gut microbiome | Altered composition of the gut microbiome | ||
- | . A decisive infectious trigger may then lead to immunization against autoantigens involved in aerobic energy production and/or hormone receptors and ion channel proteins, producing postexertional malaise and ME/CFS, affecting both muscle and brain.(({{pubmed> | + | A decisive infectious trigger may then lead to immunization against autoantigens involved in aerobic energy production and/or hormone receptors and ion channel proteins, producing postexertional malaise and ME/CFS, affecting both muscle and brain.(({{pubmed> |
Line 77: | Line 79: | ||
Patients with CFS showed abnormalities in 20 metabolic pathways. (({{pubmed> | Patients with CFS showed abnormalities in 20 metabolic pathways. (({{pubmed> | ||
+ | |||
+ | [[http:// | ||
=====Symptoms===== | =====Symptoms===== | ||
Line 146: | Line 150: | ||
- | Today scientific evidence | + | Today scientific evidence |
+ | |||
+ | |||
+ | In October 2009, we reported the first direct isolation of infectious xenotropic murine leukemia virus-related virus (XMRV). In that study, we used a combination of biological amplification and molecular enhancement techniques to detect XMRV in more than 75% of 101 patients with chronic fatigue syndrome (CFS).(({{pubmed> | ||
===== Impairment of immune function ===== | ===== Impairment of immune function ===== | ||
Line 225: | Line 233: | ||
< | < | ||
- | The length of time it takes an MP patient to return to a given level of functionality seems to vary somewhat by disease. Diseases like CFS and Lyme may take longer. This may be because patients with these diseases tend to be sicker than most. | + | The length of time it takes an MP patient to return to a given level of functionality seems to vary somewhat by disease. Diseases like CFS and Lyme are likely to take longer. This may be because patients with these diseases tend to be sicker than most. |